PCM
LLY icon

Prelude Capital Management’s Eli Lilly LLY Stock Holding History

Prelude Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,100
Closed -$123K – 2105
2019
Q3 		$123K Buy
+1,100
New +$122K 0.01% 888
2019
Q2 		– Sell
-25,000
Closed -$3.24M – 1927
2019
Q1 		$3.24M Buy
25,000
+24,900
+24,900% +$3.03M 0.18% 100
2018
Q4 		$12K Buy
+100
New +$11.2K ﹤0.01% 1338

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prelude Capital Management's LLY Position: Q1 2026 in Review

Prelude Capital Management reduced its Eli Lilly (LLY) stake by 38% in Q1 2026, selling an estimated $1.79M and leaving 2,830 shares worth $2.6M. The position accounts for 0.2% of the portfolio, ranked #122.

Prelude Capital Management first reported a position in LLY in Q2 2013 and has held it in 40 quarters since. The position peaked at $6.91M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prelude Capital Management held 2,830 shares of Eli Lilly worth $2.6M as of Q1 2026.
  • Prelude Capital Management sold 1,770 Eli Lilly shares in Q1 2026, an estimated $1.79M.
  • Eli Lilly made up 0.2% of Prelude Capital Management's portfolio in Q1 2026, its #122 holding.
  • Prelude Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 40 quarters since.
  • Prelude Capital Management's Eli Lilly position peaked at $6.91M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.